Comments on: Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19

Comments on: Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19 https://russian.lifeboat.com/blog/2021/09/japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19 Safeguarding Humanity Fri, 17 Sep 2021 14:22:58 +0000 hourly 1 https://wordpress.org/?v=6.0.2